在严重喘中使用口服皮质类固醇的负担:挑战和机遇
G Walter Canonica1,2, Celeste Porsbjerg3, David B Price4,5
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Allergy
|June 23, 2025
概括
口服皮质类固醇 (OCS) 对喘至关重要,但会引起副作用. 生物药物为减少严重喘中OCS使用提供了替代方案,改善了患者的治疗结果并降低了风险.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 口服皮质类固醇 (OCS) 几十年来一直是喘管理的基石.
- 长期使用OCS与显著的不良事件,并发症 (骨质疏松症,糖尿病),增加死亡率和更高的医疗保健成本有关.
- 尽管建议尽量减少OCS,但许多严重喘患者仍然在长期或频繁的短期OCS中.
研究的目的:
- 审查OCS在严重喘管理中的好处和负担.
- 探索减少严重喘患者对OCS依赖的策略.
- 突出生物制剂在预防严重喘的OCS中的作用.
主要方法:
- 临床试验和真实世界研究对严重喘中OCS使用的综述.
- 分析患者和医疗保健提供者对OCS好处和负担的观点.
- 讨论OCS逐渐缩减策略和管理计划.
主要成果:
- 生物疗法在2型炎症的严重喘中显示出显著的短期和长期OCS缓解作用.
- 患者和提供者的观点揭示了与OCS使用相关的挑战和好处.
- 有效的OCS减少需要谨慎的逐渐减少协议和多学科的合作.
结论:
- 由于相关风险,最大限度地减少严重喘中的OCS至关重要.
- 生物药物是减少符合条件的患者OCS负担的关键策略.
- 实施强有力的OCS管理,包括明确的逐渐减少指导方针和综合护理,对于安全有效的喘管理至关重要.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
COPD: Management Using Bronchodilators and Corticosteroids
329
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
329
Inhaled Medications
414
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
414
Asthma: Pathogenesis and Management
618
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
618
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
484
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
484


